Neumora Therapeutics Inc.

Neumora Therapeutics Inc.

World Rank (Aug-2026)
14251
Market Cap (Aug-2026)
0.296 Billion USD
Market Cap (Mar-08-2026)
0.505 Billion USD
World Rank (Jan-05-2024)
4,950
Market Cap (Jan-05-2024)
2.503 Billion USD
World Rank (Jul-30-2023)
6,835
Market Cap (Jul-30-2023)
1.515 Billion USD
Headquarters Country
USA
Nasdaq / NYSE Code
NMRA
Headquarters City/State
Massachusetts
World Region
Americas
World Subregion
Northern America
Annual Operating Income in USD
-241 Million USD
Annual Net Income in USD
-237 Million USD
Annual Results for Period Ending
For year ending December-2025
Total Assets in USD
191 Million USD
Total Liabilities in USD
87 Million USD
Total Equity in USD
104 Million USD
Balance Sheet for Period Ending
As of December-2025
Business Sector
Biopharmaceutical
Healthcare
Company Website
NEUMORA THERAPEUTICS INC.
Yahoo
Yahoo @ Nasdaq
Company Profile

Neumora Therapeutics Inc. is a biopharmaceutical company currently working on Neuroscience Drug Development to Pioneer a New Era of Medicines for Brain Diseases. Headquarters is in USA.

IPO Year
2023

Share